Treatment of acute variceal bleeding

Digestive and Liver Disease

Volumn 40, Issue 5, 2008, Pages 328-336

  Bendtsen, F ^a   Krag, A ^a   Moller S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Evidence based; Review; Treatment; Variceal bleeding; Varices

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ENBUCRILATE; FRESH FROZEN PLASMA; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; OCTREOTIDE; PLACEBO; PLASMA SUBSTITUTE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN; TISSUE ADHESIVE; VASOACTIVE AGENT; VASOPRESSIN;

ACUTE DISEASE; AIRWAY CONDUCTANCE; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG ABSORPTION; DRUG COST; DRUG PREFERENCE; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; EVIDENCE BASED MEDICINE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPOVOLEMIA; INFECTION RISK; INTESTINE INFARCTION; LIMB ISCHEMIA; MONOTHERAPY; MORTALITY; NEPHROTOXICITY; OPTIMAL DRUG DOSE; OVERALL SURVIVAL; PORTAL VEIN BLOOD PRESSURE; PROGNOSIS; RECURRENT DISEASE; RESUSCITATION; SCLEROTHERAPY; SINGLE DRUG DOSE; STANDARDIZATION; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ACUTE DISEASE; COAGULANTS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HORMONES; HUMANS; SCLEROTHERAPY; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 41849103468     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.12.005     Document Type: Article

References (64)

1. D'Amico G., and de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. Teres J., Bordas J.M., Bru C., Diaz F., Bruguera M., and Rodes J. Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations. Gut 17 (1976) 37-40
3. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Levy V.G., and Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
4. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98 (2003) 653-659
5. Graham D.Y., and Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 80 (1981) 800-809
6. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen Esophageal Varices Sclerotherapy Project. N Engl J Med 1984;311:1594-1600.
7. D'Amico G., Pagliaro L., and Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19 (1999) 475-505
8. Bosch J., and Abraldes J.G. Variceal bleeding: pharmacological therapy. Dig Dis 23 (2005) 18-29
9. D'Amico G., Pietrosi G., Tarantino I., and Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis 2. Gastroenterology 124 (2003) 1277-1291
10. Krige J.E., Kotze U.K., Bornman P.C., Shaw J.M., and Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg 244 (2006) 764-770
11. Schuman B.M., Beckman J.W., Tedesco F.J., Griffin Jr. J.W., and Assad R.T. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 82 (1987) 823-830
12. Hou M.C., Lin H.C., Kuo B.I., Lee F.Y., Schmidt C.M., and Lee S.D. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroenterol 91 (1996) 2103-2109
13. Moitinho E., Escorsell A., Bandi J.C., Salmeron J.M., Garcia-Pagan J.C., Rodes J., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117 (1999) 626-631
14. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
15. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
16. de Franchis R. Portal hypertension IV. Proceedings of the Fourth Baveno International Workshop (2006), Blackwell Publishing Ltd., Oxford
17. Cardenas A., Gines P., Uriz J., Bessa X., Salmeron J.M., Mas A., et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34 (2001) 671-676
18. Kravetz D., Sikuler E., and Groszmann R.J. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology 90 (1986) 1232-1240
19. Panes J., Teres J., Bosch J., and Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 33 (1988) 454-459
20. Cook D., and Laine L. Indications, technique, and complications of balloon tamponade for variceal gastrointestinal bleeding. J Intensive Care Med 7 (1992) 212-218
21. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002:CD002907.
22. Bernard B., Grange J.D., Khac E.N., Amiot X., Opolon P., and Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29 (1999) 1655-1661
23. Vivas S., Rodriguez M., Palacio M.A., Linares A., Alonso J.L., and Rodrigo L. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci 46 (2001) 2752-2757
24. Hou M.C., Lin H.C., Liu T.T., Kuo B.I., Lee F.Y., Chang F.Y., et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39 (2004) 746-753
25. Fernandez J., Ruiz del A.L., Gomez C., Durandez R., Serradilla R., Guarner C., et al. Norfloxacin vs. ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131 (2006) 1049-1056
26. Cabrera J., Arroyo V., Ballesta A.M., Rimola A., Gual J., Elena M., et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82 (1982) 97-105
27. Sola-Vera J., Minana J., Ricart E., Planella M., Gonzalez B., Torras X., et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 37 (2003) 1147-1153
28. Vinel J.P., Cassigneul J., Levade M., Voigt J.J., and Pascal J.P. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology 6 (1986) 116-117
29. Villanueva C., Ortiz J., Minana J., Soriano G., Sabat M., Boadas J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 121 (2001) 110-117
30. Levacher S., Letoumelin P., Pateron D., Blaise M., Lapandry C., and Pourriat J.L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346 (1995) 865-868
31. Moller S., Hansen E.F., Becker U., Brinch K., Henriksen J.H., and Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 20 (2000) 51-59
32. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003:CD002147.
33. Feu F., Ruiz del A.L., Banares R., Planas R., Bosch J., and Variceal Bleeding Study Group. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 111 (1996) 1291-1299
34. Walker S., Kreichgauer H.P., and Bode J.C. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology 15 (1992) 1023-1030
35. Walker S., Kreichgauer H.P., and Bode J.C. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices-final report of a placebo-controlled, double-blind study. Z Gastroenterol 34 (1996) 692-698
36. Escorsell A., Ruiz del A.L., Planas R., Albillos A., Banares R., Cales P., et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 32 (2000) 471-476
37. Krag A., Moller S., Henriksen J.H., Holstein-Rathlou N., Larsen F., and Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 46 (2007) 1863-1871
38. Fabrizi F., Dixit V., and Martin P. Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther 24 (2006) 935-944
39. Moreau R., and Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 43 (2006) 385-394
40. Bosch J., Kravetz D., and Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 80 (1981) 518-525
41. Baik S.K., Jeong P.H., Ji S.W., Yoo B.S., Kim H.S., Lee D.K., et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 100 (2005) 631-635
42. Moller S., Brinch K., Henriksen J.H., and Becker U. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 26 (1997) 1026-1033
43. Ottesen L.H., Flyvbjerg A., Moller S., and Bendtsen F. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients. Aliment Pharmacol Ther 12 (1998) 657-665
44. Escorsell A., Bandi J.C., Andreu V., Moitinho E., Garcia-Pagan J.C., Bosch J., et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120 (2001) 161-169
45. Burroughs A.K., McCormick P.A., Hughes M.D., Sprengers D., D'Heygere F., and McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 99 (1990) 1388-1395
46. Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev 2005:CD000193.
47. Banares R., Albillos A., Rincon D., Alonso S., Gonzalez M., Ruiz-del-Arbol L., et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35 (2002) 609-615
48. Ejlersen E., Melsen T., Ingerslev J., Andreasen R.B., and Vilstrup H. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 36 (2001) 1081-1085
49. Bosch J., Thabut D., Bendtsen F., D'Amico G., Albillos A., Gonzalez A.J., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
50. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al. Recombinant factor VIIa (rFVIIa) for active variceal bleeding in patients with advanced cirrhosis: a multi-center randomised double-blind placebo-controlled trial. Hepatology 2008 (in press).
51. de Franchis R., and Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 19 (1999) 439-455
52. Laine L., and Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123 (1995) 280-287
53. Lo G.H., Lai K.H., Cheng J.S., Lin C.K., Huang J.S., Hsu P.I., et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 25 (1997) 1101-1104
54. Villanueva C., Piqueras M., Aracil C., Gomez C., Lopez-Balaguer J.M., Gonzalez B., et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 45 (2006) 560-567
55. Krag A., Adamsen S., and Bendtsen F. Endoscopic treatment of bleeding esophageal varices. Endoscopy 39 (2007) 373
56. Sarin S.K., Lahoti D., Saxena S.P., Murthy N.S., and Makwana U.K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16 (1992) 1343-1349
57. Kim T., Shijo H., Kokawa H., Tokumitsu H., Kubara K., Ota K., et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 25 (1997) 307-312
58. Gimson A.E., Westaby D., and Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 13 (1991) 274-278
59. Lo G.H., Lai K.H., Cheng J.S., Chen M.H., and Chiang H.T. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33 (2001) 1060-1064
60. Sarin S.K., Jain A.K., Jain M., and Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 97 (2002) 1010-1015
61. Roesch W., and Rexroth G. Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 30 (1998) S89-S90
62. Chau T.N., Patch D., Chan Y.W., Nagral A., Dick R., and Burroughs A.K. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114 (1998) 981-987
63. Teres J., Planas R., Panes J., Salmeron J.M., Mas A., Bosch J., et al. Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial. Hepatology 11 (1990) 964-968
64. Tripathi D., Ferguson J.W., Therapondos G., Plevris J.N., and Hayes P.C. Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther 24 (2006) 1-17